AceTech develops precision medicine technology for the prediction of adverse effects and prescription products for their prevention and management. A privately owned, vertically integrated (from plantation to final product) biotechnology company, AceTech executes transitional research to create precision medicine solutions and develop biopharmaceutical Rx and OTC products targeting the skin and dental care markets.
The company uses biomedical sensors, artificial intelligence, big data algorithms, and microbiome profiling to collect, connect, and analyze big data measurements and create an individual skin signature which is then translated into a personalized prescription and recommendations. Its prescription products are designed to provide a four-R solution: The Right patient, with the Right product, at the Right dose, and on the Right schedule for its prevention and management.
AceTech utilizes ACEMANNAN as the core and propriety active ingredient to manufacture and commercialize its branded products. The companys headquarters are in Israel, with the plantation and GMP manufacturing facilities of the active ingredient located in Costa Rica.